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Abstract 
Background: Gastric cancer (GC) remains a public health issue 
despite the global incidence decrease over the last decades. GC is the third 
leading cause of cancer-related death worldwide and it is still of poor 
prognosis due to its late detection. This paper focuses on determining the 
sociodemographic and progressive characteristics of patients who presented 
gastric adenocarcinoma in the absence or in the presence of the bacterium 
Helicobacter pylori at the service of Hepato-Gastroenterology at the 
University Hospital of Rabat in Morocco. Methods: To evaluate the 
epidemiological characteristics of gastric adenocarcinoma in the absence or in 
the presence of the bacterium Helicobacter pylori, a retrospective study was 
conducted on cases admitted at the Hepato-Gastroenterology department 
(University Hospital, Avicene Rabat) between 2000 and 2010 to support 
gastric adenocarcinoma. Results: 240 cases of GC were recorded with an 
average of 22 cases per year, which represents 77% of all gastric cancers 
identified. Male gender is most affected. The frequency of appearance of ADK 
in the absence of the bacterium Hp is 82% (196 cases). It is 18% (44 cases) in 
the presence of Hp. During the study period, 99 deaths were recorded: 81 cases 
in the presence of the bacterium Helicobacter pylori, 18 cases of death in the 
absence of Hp. The lethality rate was higher in the male sex, either in the 
presence or absence of Hp. Conclusions: Management of GC additionally to 
early diagnosis represents effective preventive and therapeutic methods of GC. 
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Introduction 
Gastric cancer (GC) remains a public health issue despite the global 
decrease in the incidence over the last decades. Approximately one million of 
new cases were diagnosed (6.8% of all cancers), making this digestive 
neoplasia the fifth most common malignancy and the third leading cause of 
cancer related-death in both genders worldwide (8.8% of the total) (Bachir et 
al., 2018). The risk is particularly higher in Eastern Asia where half of the 
world total occurs mainly in China and Japan. Although the African continent 
is considered as a low incidence area, 13,216 new cases of stomach cancer 
were diagnosed and 12,000 cases of death were recorded in 2012 (Ferlay et 
al., 2012).  
The most common histologic entity of GC is adenocarcinoma, 
accounting for 90% of all stomach tumors (Carl-McGrath et al., 2008). Sixty 
percent to Seventy percent of GCs represent the final step of mucosal 
precancerous inflammatory process induced by Helicobacter pylori (HP) 
infection (Malfertheiner). The pre-neoplastic cascade is initiated by atrophic 
chronic gastritis (ACG) which may persist and advance to intestinal 
metaplasia when compared to dysplasia. ACG and IM are considered as 
reversible steps regressing by the bacterium eradication (Carl-McGrath, 2014; 
Correa & Piazuelo, 2013). Thus, this paper focuses on determining the 
sociodemographic and progressive characteristics of patients who presented 
gastric adenocarcinoma in the absence or in the presence of the bacterium 
Helicobacter pylori.  
 
Materials and Methods 
This is a descriptive retrospective study, during the period 2000 and 
2010, which was conducted based on the records of patients in which their 
biopsies made during the examination of their stomachs by fibroscopy in the 
Department were consulted of Hepato-Gastroenterology at the University 
Hospital Center in Rabat, Morocco. 
The statistical methodology was based on two axes: 
 Descriptive Statistics: This involves the disengagement of frequencies 
and characteristics of each parameter studied. The results are expressed 
in raw values for the qualitative variables and in means ± error of the 
mean for the quantitative variables. 
 Analytical Statistics: The χ² test and the reduced gap calculation (ε) are 
used to determine whether a difference between some variables is 
significant. The calculation of the odds ratio (OR) informs us about the 
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liaison of the various factors with the evolution of the 
adenocarcinomatous patients. On the other hand, we detected the 
degree of association between the location of gastric cancer and the 
presence or absence of Helicobacter pylori (Hp) bacteria. 
 
Results 
During the study period, we collected 240 cases of gastric 
adenocarcinomas in the Hepato-Gastroenterology Department of Ibn Sina 
Hospital, Rabat Medicine Service B in Morocco. The average annual number 
of cases recorded was 22 cases per year, which represents 77% of all gastric 
cancers recorded. The frequency of appearance of ADK in the absence of the 
Hp bacterium shows that the years, 2001, 2008 and 2010, are the highest with 
25, 28 and 25 cases respectively. This, however, is contrary to the year 2002 
which reported too few with only 5 cases (Figure 1). 
During the same study period, a total of 44 cases of Hp-associated 
ADK were recorded at the rate of 18%. The temporal distribution during 
collection years shows high peaks and low peaks (Figure 1).  
 
Figure 1. Temporal evolution of ADKs 
 
According to the years of the 240 cases, 99 cases died (41% of the total 
patients). The average annual number of deaths is 9 ± 0.94 cases per year, with 
extremes ranging from 1 to 16 deaths. Figure 2 illustrates the annual 
distribution of the number of deaths of ADK in the presence (81 cases of 
death) and in the absence of the bacterium Helicobacter pylori (18 cases of 
death). 
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Figure 2. Annual distribution of deaths and case lethality rate 
 
Furthermore, the distribution of cases of ADK deaths, not associated 
with Helicobacter pylori infection by sex, shows that 48 cases of death were 
male (59%) and 33 cases (41%) were female (Table 1) with a sex ratio (M/F) 
of 1.2 (χ2 = 2.78, p = 0.09). The highest case lethality rate was observed in 
males at 24%, compared with 17% for females. The difference is not 
significant between the two sexes in terms of lethality (ε = 1.2). 
Similarly for patients who developed an ADK associated with 
Helicobacter pylori infection, it was shown that 10 deceased cases are male 
with a frequency of 55% and 8 of them are female which is 45% (χ2 = 0.22; = 
0.6). Similarly, the case lethality rate is higher in the male sex with 23% 
compared to 18% in the female sex. The difference is not significant (ε = 0.26) 
in terms of lethality between the two sexes. 
Indeed, the highest frequency of patients who have died from this type 
of cancer is aged 60 to 79, either in the absence or in the presence of the 
bacterium Helicobacter pylori with a case-fatality rate of 28% (n = 68 cases). 
This was followed by the 50-59 age group, with a case-lethality rate of 9% (n 
= 21 cases), and then the age of 80 or older with a case-fatality rate of 4% (n 
= 10 cases) (Table 1). 
Table 1. Epidemiological characteristics of deceased patients 
Variable ADK ADK+Hp  Lethality ADK (%) Lethality ADK+Hp(%) 
Gender     
Female 23 8 12 18 
Male 58 10 30 23 
Total 81 18   
Age group     
[50-60[ 17 4 9 20 
[60-70[ 26 8 13 18 
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[70-80[ 28 6 14 14 
>=80 10 - 5 - 
Total 81 18   
 
Furthermore, we studied the effect of certain factors on the evolution 
of patients. The independence test χ 2 and the Odds Ratio are calculated to 
identify the risk factors that would have affected the progression of the state 
of health of adenocarcinomatous patients in our series. Table 2 mentions the 
analysis of the association between evolution and the socio-epidemiological 
and evolutionary parameters that were studied. 
Table 2. Risk factors that influence the evolution of patients 
Associated factor Favorable Death χ2 to 1ddl p OR CI  to 95 % 
Sex 
 
     
  
Female 66 41 0,69 NS 0,8 0,48-1,34 
Male 75 58 
  
1,24 0 ,74-2,08 
Total 141 99 
    
Age group (Years) 
 
 
    
[10-20[ -  
    
[20-30[ 6 - 
  
- 
 
[30-40[ 14 - 
  
- 
 
[40-50[ 37 - 
  
- 
 
[50-60[ 37 18 2,14 NS 0,62 0,33-1,17 
[60-70[ 35 37 4,36 S 1,81 1,04-3,16 
[70-80[ 9 34 30,92 HS 7,67 3,47-16,94 
≥80 3 10 8,35 VS 5,75 1,54-21,51 
Total 141 99 
    
Toxic habits 
 
 
    
Alcohol 1 1 0,02 NS 1,25 0,08-20,69 
Tobacco 20 18 1,66 NS 1,75 0,75-4,11 
Alcohol +Tobacco  21 13 0,94 NS 0,64 0,26-1,56 
Non-Steroidal Anti-Inflammatories 3 5 1,08 NS 2,19 0,49-9,85 
Plant 0 1 1,26 NS - - 
Total 45 37     
H.pylori       
Hp+ 26 18 1,33 NS 0,68 0,35-1,32 
Hp- 97 99   1,47 0,76-2,85 
Total 123 117     
NS : No significant liaison -S : Significant liaison -VS : Very significant  -HS : Highly significant 
liaison- Hp+: Presence of helicobacter pylori, Hp- : Absence of helicobacter pylori 
 
The studied variables include Sex, age group, toxic habits, presence of 
helicobacter pylori (Hp +), and absence of helicobacter pylori (Hp-). The sex 
of the patients did not have a significant association with the death. Patients 
over the age of 60 have shown a risk of progression to death. This risk is 
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accentuated in the older group of 60-70 years (OR = 7.67 to 95% CI [3.47-
16.94]), as well as those aged 80 years and above (OR = 5.75 at CI at 95% 
[1.54-21.51]). Adenocarcinomatous patients with toxic habits such as alcohol, 
tobacco, alcohol + tobacco, plants, and Non-Steroidal Anti-Inflammatories did 
not mount a significant association with the development of the disease. 
According to the results of Table 2, no risk was shown in the absence or 
presence of the Hp bacteria. 
On the other hand, we have studied the influence of Hp on the 
localization of gastric adenocarcinoma (Table 3). According to the results of 
Table 3, there is no significant difference between the presence or absence of 
the bacterium Hp and the different localizations studied. 
Table 3. Distribution of odds ratio for the location according  
to the presence or absence of Hp 
Localization Antral χ2 P OR CI to  95% 
n (Hp+) 29 2,78 0,09 1,78 0,9-3,52 
n (Hp-) 102   0,56 0,28-1,11 
 Cardia     
n (Hp+) 1 4,34 0,03 0,15 0,02-1,15 
n (Hp-) 26   6,57 0,86-49,8 
 Fundus     
n (Hp+) 9 0,02 0,89 0,94 0,42-2,11 
n (Hp-) 42   1,06 0,47-2,38 
 Pangastrique     
n (Hp+) 5 0,12 0,73 0,83 0,30-2,32 
n (Hp-) 26   1,19 0,43-3,30 
Hp+: presence of helicobacter pylori, Hp- : absence of helicobacter pylori 
 
Discussion 
Stomach cancer is essentially represented by gastric adenocarcinomas, 
which remains one of the top ten global causes of mortality with a prognosis 
that is pejorative. They are about 90% of cases where adenocarcinoma was 
developed at the expense of the gastric epithelium. Other tumors are 
lymphoma (5%), neuroendocrine tumors, and stromal tumors (Gallo & Cha, 
2006). Gastric adenocarcinoma remains one of the top 10 global causes of 
cancer-related mortality due to poor prognosis (Aparicio et al., 2004). 
It is a cancer with variable incidence worldwide, the highest in East 
Asia (Japan, China and Korea), and 102,040 new cases were reported in Japan 
in 2008 (Yingsong et al., 2011). A total of 240 cases of ADK were collected 
during the study period, with an annual average of 22 cases / year, which 
represents 77% of all gastric cancers identified. In other works, the ADK 
represented a frequency of 70.1 to 100% (Ayite et al., 2004; Biffi et al., 2010), 
which confirms our results. During the study period, 99 cases of death were 
recorded at a rate of 41%. This result is similar with the literature (Bouglouga 
et al., 2011) which is of the order of 40%. The average age of patients is 59 ± 
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0.93 years, with a minimum age of 22 years and a maximum age of 90 years, 
which seems consistent with other publications (Luis et al., 2007; Ilter et al., 
2010).   
The frequency of this cancerous pathology is twice as high in males 
(63.77%) as in females, with a highly significant difference (p <0.001) 
according to our study. This situation is similar to other results whose sex ratio 
was M F = 2 (Aparicio et al., 2004). 
High male risk is related to more frequent toxic habits in men and, in 
the majority of cases, it is related to smoking and / or alcoholism, occupational 
exposure, and environmental and carcinogenic substances (Neuberger et al., 
2006; Martinez  et al., 2005). 
According to our study, the frequency of the association of 
Helicobacter pylori with the presence of gastric adenocarcinomas is 18%. In 
other studies, the frequency of Helicobacter pylori is about 15% (Enneddam, 
2008). 
Several environmental factors, genetic, and a number of conditions 
have been incriminated as etiopathogenic factors in the occurrence of gastric 
cancer. 
Smoking has been shown to induce gastric cancer and was classified 
by the International Cancer Research Agency as a group 1 gastric carcinogen. 
In our study, no significant difference was found between smoking and the 
occurrence of ADK (p> 0.05), which is consistent with a German study 
(Bornschein et al., 2011). Similarly, nonsteroidal anti-inflammatory drugs 
have no significant effect on the development of ADK according to our study. 
In other work, these anti-inflammatories have an effect on carcinogenicity 
(Glehen et al., 2000). 
On the other hand, in our study, alcohol represents 3% of all toxic 
habits. In other publications, the concept of alcoholism was found in 2.79% of 
patients (Salmi, 1995).  This discrepancy is due to the number of cases 
collected from one study to another. However, in all cases, studies have shown 
that there is no obvious relationship in the occurrence of gastric ADK and 
alcohol consumption (Aparicio et al., 2004), which is consistent with our 
results. The gastric cancers sit more frequently in the zones of mucous junction 
in the prepyloric region, in the antrum, and in the small curvature. The antral 
location represents 60%. This percentage matches that of our study which was 
55%. In other works, it is respectively 50.3%, 50%, and 52% (Glehenal, 2000; 
Marcato, 2007; Nakamura et al., 2002).  
 
Conclusion 
Gastric cancer is a real health problem. Hence, there is the need to 
organize information and education campaigns in order to encourage people 
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to consult early on functional signs and to treat patients early in order to 
control the disease and avoid deadly results.  
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